Christoforos Meliadis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Christoforos Meliadis has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Alena D. Larios
Department of Orthopaedic Surgery, University of California, San Francisco, CA
1 shared publication - Ali Maaz
North Central Bronx Hospital/Jacobi Medical Center, NYC Health + Hospitals, Albert Einstein College of Medicine, Bronx, NY 10467, USA
1 shared publication - Armend Balidemaj
North Central Bronx Hospital/Jacobi Medical Center, NYC Health + Hospitals, Albert Einstein College of Medicine, Bronx, NY 10467, USA
1 shared publication - Ashwin Ragupathi
North Central Bronx Hospital/Jacobi Medical Center, NYC Health + Hospitals, Albert Einstein College of Medicine, Bronx, NY 10467, USA
1 shared publication - Bryant Lin
Stanford University
1 shared publication - Camillo Duarte Calderon
North Central Bronx Hospital/Jacobi Medical Center, NYC Health + Hospitals, Albert Einstein College of Medicine, Bronx, NY 10467, USA
1 shared publication
Latest Publications
- Open Access
- 30 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (21) , 3595
Imaging- and Device-Based Congestion Assessment to Guide Chronic Heart Failure Management: A Systematic Review and Network Meta-Analysis
Background/Objectives: Congestion drives most heart-failure (HF) hospitalizations, and several strategies now titrate therapy to a directly measured congestion signal rather than to symptoms; whether they differ by the signal measured has not been examined comparatively. Methods: We performed a systematic review and contrast-based network meta-analysis of randomized trials comparing imaging- or device-based congestion-triggered management with usual care. Thirteen chronic-phase trials formed a star network (no closed loops; rankings exploratory) of four strategies, pressure-guided (N1), lung ultrasound (N2), transthoracic lung impedance (N3), and cardiac-implantable-electronic-device (CIED) intrathoracic impedance (N5), with HF hospitalization as the primary outcome and six prespecified sensitivity analyses; four acute trials formed a gap map. Results: Only pressure-guided monitoring reduced HF hospitalization (0.72, 95% confidence interval 0.57–0.90), stable across sensitivities and matching external data. Lung ultrasound did not reduce hospitalization (0.72, 0.48–1.08) or mortality but reduced urgent visits (0.26, 0.13–0.50). The apparent CIED-impedance harm (1.12, 0.77–1.63) reflected an audible-alert trial and dissolved when early-terminated trials were excluded (0.87). Lung impedance gave the largest estimate (0.51, 0.31–0.83) but rested on one trial. No strategy tested in more than one trial reduced mortality. Conclusions: The congestion signal acted upon, and who receives the alert, track with the effect, although signal and workflow cannot be separated within trials; clinicians should match modality to the intended outcome, as these tools defer hospitalization, not death.
- 30 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (21) , 3595
Open AccessImaging- and Device-Based Congestion Assessment to Guide Chronic Heart Failure Management: A Systematic Review and Network Meta-Analysis
Background/Objectives: Congestion drives most heart-failure (HF) hospitalizations, and several strategies now titrate therapy to a directly measured congestion signal rather than to symptoms; whether they differ by the signal measured has not been examined comparatively. Methods: We performed a systematic review and contrast-based network meta-analysis of randomized trials comparing imaging- or device-based congestion-triggered management with usual care. Thirteen chronic-phase trials formed a star network (no closed loops; rankings exploratory) of four strategies, pressure-guided (N1), lung ultrasound (N2), transthoracic lung impedance (N3), and cardiac-implantable-electronic-device (CIED) intrathoracic impedance (N5), with HF hospitalization as the primary outcome and six prespecified sensitivity analyses; four acute trials formed a gap map. Results: Only pressure-guided monitoring reduced HF hospitalization (0.72, 95% confidence interval 0.57–0.90), stable across sensitivities and matching external data. Lung ultrasound did not reduce hospitalization (0.72, 0.48–1.08) or mortality but reduced urgent visits (0.26, 0.13–0.50). The apparent CIED-impedance harm (1.12, 0.77–1.63) reflected an audible-alert trial and dissolved when early-terminated trials were excluded (0.87). Lung impedance gave the largest estimate (0.51, 0.31–0.83) but rested on one trial. No strategy tested in more than one trial reduced mortality. Conclusions: The congestion signal acted upon, and who receives the alert, track with the effect, although signal and workflow cannot be separated within trials; clinicians should match modality to the intended outcome, as these tools defer hospitalization, not death.
- Open Access
- 27 December 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (4) , 575-588
Osteocyte-Intrinsic MMP13 exacerbates injury-induced temporomandibular joint osteoarthritis
- 27 December 2025
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 34 (4) , 575-588
Open AccessOsteocyte-Intrinsic MMP13 exacerbates injury-induced temporomandibular joint osteoarthritis
- Open Access
- 12 December 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Open Journal of Engineering in Medicine and Biology
- Vol. 6, 256-260
Estimating Maxillary Sinus Volume Using Smartphone Camera
Goal: This study aims to introduce a novel method for estimating maxillary sinus volume using smartphone technology, providing an accessible alternative to traditional imaging techniques. Methods: We recruited 40 participants to conduct a comparative analysis between Computed Tomography (CT) and face scans obtained using an Apple iPhone. Utilizing Apple's ARKit for 3D facial mesh modeling, we estimated sinus dimensions based on established craniofacial landmarks and calculated the volume through a geometric approximation of the maxillary sinus. Results: We demonstrated a high degree of agreement between CT and face scans, with Mean Absolute Percentage Errors (MAPE) of 8.006 ± 8.839% (Width), 6.725 ± 4.595% (Height), 9.952 ± 6.733% (Depth), and 10.429 ± 7.409% (Volume). These results suggest the feasibility of this non-invasive approach for clinical use. Conclusions: This method aligns with the growing focus on telemedicine, presenting significant reductions in healthcare costs and radiation exposure from CT scans. It marks a substantial advancement in otolaryngology and maxillofacial surgery, showcasing the integration of smartphone technology in medical diagnostics and opening avenues for innovative, patient-friendly, and cost-effective healthcare solutions.
- 12 December 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Open Journal of Engineering in Medicine and Biology
- Vol. 6, 256-260
Open AccessEstimating Maxillary Sinus Volume Using Smartphone Camera
Goal: This study aims to introduce a novel method for estimating maxillary sinus volume using smartphone technology, providing an accessible alternative to traditional imaging techniques. Methods: We recruited 40 participants to conduct a comparative analysis between Computed Tomography (CT) and face scans obtained using an Apple iPhone. Utilizing Apple's ARKit for 3D facial mesh modeling, we estimated sinus dimensions based on established craniofacial landmarks and calculated the volume through a geometric approximation of the maxillary sinus. Results: We demonstrated a high degree of agreement between CT and face scans, with Mean Absolute Percentage Errors (MAPE) of 8.006 ± 8.839% (Width), 6.725 ± 4.595% (Height), 9.952 ± 6.733% (Depth), and 10.429 ± 7.409% (Volume). These results suggest the feasibility of this non-invasive approach for clinical use. Conclusions: This method aligns with the growing focus on telemedicine, presenting significant reductions in healthcare costs and radiation exposure from CT scans. It marks a substantial advancement in otolaryngology and maxillofacial surgery, showcasing the integration of smartphone technology in medical diagnostics and opening avenues for innovative, patient-friendly, and cost-effective healthcare solutions.